Out Of The Blocks, February 2013
Brief profiles of these recently formed companies: ArthroCAD, Carmenta Bioscience, Helmedix, MediBeacon, SulfaGENIX, and ViroCyt.
You may also be interested in...
A collaboration between Novo and Fauna will look at animal hibernation and genetic sequencing for hints toward novel therapies for obesity. Pfizer will use Insilico’s machine learning technology in target validation.